Clik here to view.
Takeda’s Uloric drug receives FDA approval for gout
Takeda’s Uloric drug receives FDA approval for goutAccording to reports by the Chicago Tribune, Takeda Pharmaceuticals' Uloric drug has received FDA's approval for treatment of gout - a painful joint...
View ArticleClik here to view.
Regulatory Delay for Takeda’s Alogliptin for Diabetes
Takeda PharmaceuticalsPPD, a drug development contractor said Friday it does not expects a $25 million payment from Japan-based Takeda Pharmaceuticals after that company raised concerns of a regulatory...
View ArticleClik here to view.
Takeda Pharmaceutical Co. Dropped by 1 percent
Takeda-Pharmaceutical8.gifAfter the investors lost their right to get dividends for the fiscal year, Japanese stocks fell for the first ever time.Drop of 1% was faced by Takeda Pharmaceutical Co.,...
View ArticleClik here to view.
FDA Panel Supports Peginesatide
Affymax-Inc-Takeda-Pharmaceuticals.jpgOn Wednesday, Affymax Inc. and Takeda Pharmaceutical Co. announced that an advisory committee of the US Food and Drug Administration has decided to support...
View ArticleClik here to view.
Takeda to Seize Distribution of Pfizer Drugs in Japan
Takeda-Pharmaceutical.jpgThe national distributor of Pfizer Inc in Japan has now decided end its role as a distributor of Pfizer drugs. Takeda Pharmaceutical Co, who is also the largest drug maker in...
View ArticleClik here to view.
FDA Approves Takeda’s Type-2 Diabetes Treatment Drug Alogliptin
Takeda-Logo.jpgTakeda Pharmaceutical Co. has received a green signal from the Food and Drug Administration for its new treatment meant for Type 2 diabetes. Takeda has received approval with the Furiex...
View ArticleClik here to view.
Affymax Recalls Anemia Drug Omontys, Shares Dip
Omontys.jpgAffymax Inc shares slashed by 85% after it recalled its commercial product Omontys, a drug for anemia patients on Saturday. There were reports of the drug causing side effects including...
View Article
